The company
ImaBiotech provides innovative services to get a better and faster drug candidate evaluations with new imaging approaches to study drug efficacy and toxicity.
|
Services
Discover ImaBiotech's various offers using cutting-edge Quantitative Mass Spectrometry Imaging to improve the drug behavior and efficacy:
- Target engagement by QMSI allows the localization of the drug, metabolites and their pharmacological target without labelling
- Pharmacokinetics and Pharmacodynamics by QMSI provides drug and metabolites distribution with companion biomarkers at whole body or cellular levels
- Toxicity studies with QMSI identify the relation between drug, metabolites and toxicity at cellular levels, improve the chemical compounds and avoid NoGo decision at later stage Phase II
PK/PD
TOXICOLOGY
TARGET ENGAGEMENT
CENTRAL NERVOUS SYSTEM
OPHTHALMOLOGY
DERMATOLOGY & COSMETICS
GASTROENTEROLOGY
CARDIOVASCULAR & METABOLICS
ONCOLOGY
RESPIRATORY DISEASES
